Cramer: Buying Trea...
Health Care: Health Services
Boston Scientific Inc. (BSX: NYSE)
$5.61 -0.13 | -2.26%
06/01/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 5.61 |
| 52 Week High | 7.55 |
| 52 Week Low | 5.01 |
| Avg. Daily Vol. (Mil) | 13.40 |
| Beta (3 year) | 0.99 |
| Share Related Items | |
| Mkt Cap (Mil) | 8,018.35 |
| Shares Out (Mil) | 1,429.30 |
| Float (Mil) | 1,432.59 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.00 |
| Current Ratio | 1.90 |
| LT Debt/ Equity | 0.37 |
| Total Debt / Equity | 0.37 |
| Valuation Ratios | |
| Price Earnings | 16.50 |
| Price/Sales | 1.06 |
| Price/Book | 0.70 |
| Price/Cash Flow | 6.50 |
| Per Share Data | |
| Earnings | 0.34 |
| Sales | 5.29 |
| Book Value | 7.97 |
| Cash Flow | 0.86 |
| Business Summary | |
|---|---|
| Boston Scientific, Inc.is the manufacturer and marketer of medical devices, used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, gynecology and neuromodulation. | |
| General Information | |
| One Boston Scientific Place
Natick, MA 01760-1537 |
|
| www.bsci.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 24000 | |
| CEO: Mr. William H. (Hank) Ku | |
| Short Interest | |
| Current Month (Mil) | 21.75 |
| Previous Month (Mil) | 26.71 |
| Short Interest Ratio (Days) | 1.20 |
| Management Effectiveness | |
| Return on Equity | 4.50 |
| Return on Assets | 2.40 |
| Return on Investments | 3.20 |
| Profitability | |
| Gross Margin | 69.20 |
| EBIT Margin | 10.10 |
| Profit Margin | 6.70 |
Portfolios with BSX
- Portfolio NameUser Type
- ProLeon Cooperman - Omega Advi...
- ContributorHealth Care Stocks Bought a...
- Contributor6 Stocks Purchased by Billi...
- Contributor8 Health Care Stocks Inside...
- UserPFE
- ContributorHigh Volume Technicals for ...
- ContributorS&P 500 Stocks With Notable...
- ProBridger Management
- UserWatch List - Healthcare / B...
- UserActual
Latest BSX Headlines from TheStreet
- Boston Scientific's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.19.12 | 01:04 pm
- Oracle, Boston Scientific: David Tepper Takes New Positions 02.24.12 | 11:02 am
- Boston Scientific Bulls Angle for Rebound 02.17.12 | 05:02 am
- 6 Stocks Purchased by Billionaire Tepper Include Oracle, Apple 02.15.12 | 09:02 am
- Boston Scientific's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.02.12 | 03:02 pm
- 8 Health Care Stocks Insiders Are Bullish on 12.28.11 | 04:12 pm
- Analysts' Actions: AMZN, BSX, DD, LOW, FSLR 12.15.11 | 09:12 am
- Boston Scientific Stock Hits New 52-Week Low (BSX) 12.12.11 | 12:12 pm
- Boston Scientific Inc. (BSX): Today's Featured Health Care Winner 12.05.11 | 04:12 pm
- 5 Things You Need to Know Before the Stock Market Opens 12.05.11 | 08:12 am
Press Releases for BSX
- Boston Scientific Announces Expanded Indication For CRE Wireguided Balloon Dilator - PR Newswire 05.29.12 | 08:05 am
- PROMUS Element⢠Stent Demonstrates Excellent Long-Term Safety And Effectiveness In PLATINUM Small Vessel Study - PR Newswire 05.18.12 | 04:05 am
- Boston Scientific Announces FDA Approval And U.S. Launch Of EPIC⢠Vascular Stent - PR Newswire 05.17.12 | 05:05 pm
- Boston Scientific Announces U.S. Launch Of Z Flex-270⢠Steerable Sheath - PR Newswire 04.11.12 | 08:04 am
- Boston Scientific To Announce First-Quarter 2012 Financial Results On April 19 - PR Newswire 04.10.12 | 02:04 pm
- Boston Scientific Launches Innovative Device Used To Prevent Stone Migration In Urologic Procedures - PR Newswire 04.02.12 | 08:04 am
- Boston Scientific Supports New Clinical Trial To Evaluate Platinum Chromium Coronary Stents In Treating Heart Attack Patients - PR Newswire 03.26.12 | 08:03 am
- Landmark Analysis Of Year Two Data From PLATINUM Workhorse Trial Demonstrates Superior Efficacy Of PROMUS Element⢠Platinum Chromium Stent Compared To PROMUS® (Xience V®) Stent - PR Newswire 03.25.12 | 12:03 pm
- Analysis Of Two Randomized Clinical Trials Identify No Cases Of Longitudinal Stent Deformation With Boston Scientific Platinum Chromium Stents - PR Newswire 03.25.12 | 12:03 pm
- Boston Scientific Announces New Clinical Data To Be Presented At ACC 2012 On The Market-Leading PROMUS Element⢠Stent - PR Newswire 03.20.12 | 08:03 am
Partner Headlines for BSX
- St. Jude Remains Neutral - Analyst Blog - Zacks 05.25.12 | 03:05 pm
- After Hours Most Active for May 18, 2012 : FB, BAC, QQQ, ARUN, PRIS/B, GE, HSY, WFC, MSFT, INTU, BSX, CSCO - NASDAQ 05.18.12 | 08:05 pm
- Boston Scientific Announces Positive Data from Lotus Transcatheter Aortic Valve Trial - Benzinga 05.15.12 | 12:05 pm
- The Zacks Analyst Blog Highlights: St. Jude Medical, Abbott Laboratories, Medtronic, Boston Scientific and Big Lots - Press Releases - Zacks 04.26.12 | 09:04 am
- ANGO Mixed, Adjusts View - Analyst Blog - Zacks 04.05.12 | 09:04 am
- Medtronic May Rise 30%, Outperforming Peers - Seeking Alpha 03.30.12 | 08:03 am
- Zacks Bull and Bear of the Day Highlights: The Kroger, Dril-Quip, Medtronic, Boston Scientific and St. Jude Medical - Press Releases - Zacks 03.27.12 | 09:03 am
- Positive Data for Medtronic's DES - Analyst Blog - Zacks 03.26.12 | 07:03 pm
- Analyzing Bank Of America's Top 5 Sells - Seeking Alpha 03.22.12 | 08:03 am
- April Stocks To Buy With Covered Calls (ROUND 2) - Seeking Alpha 03.20.12 | 09:03 am
